Zimmer Biomet breached deferred
prosecution deal, U.S. says
Send a link to a friend
[June 15, 2016]
By Brendan Pierson
NEW YORK (Reuters) - Medical device maker
Biomet Inc breached a deferred prosecution agreement it reached in 2012
to resolve a foreign corruption investigation, U.S. prosecutors said in
a court filing.
|
In a status report filed in federal court in Washington, D.C. on
June 6, the U.S. Department of Justice said Biomet breached the
agreement through activity in Brazil and Mexico that it disclosed in
2014, and by failing maintain a corporate compliance program.
The finding means the company could face criminal prosecution,
though the Justice Department said the company had pledged to
cooperate and was in "discussions to resolve this matter which would
obviate the need for a trial."
Indiana-based Biomet, now called Zimmer Biomet Holdings Inc after
being acquired by Zimmer Holdings last year, did not immediately
respond to a request for comment.
Biomet entered into the deferred prosecution agreement to settle
allegations that it paid bribes to state-employed healthcare
providers in Argentina, Brazil and China in order to secure business
with hospitals, the Justice Department said in 2012.
Prosecutors said Biomet disguised those payments in its financial
reports as "commissions," "consulting fees," "royalties" and
"scientific incentives."
The company also agreed to pay a $17.3 million criminal penalty,
along with a $5.4 million civil settlement to the U.S. Securities
and Exchange Commission, and to maintain a compliance program to
prevent future misconduct.
[to top of second column] |
The Justice Department said Biomet's conduct violated the Foreign
Corrupt Practices Act, which prohibits bribery of foreign officials.
It agreed not to prosecute the company if it abided by the deal for
three years.
However, the agreement has since been extended for two successive
years as prosecutors have continued to investigate Biomet's conduct.
The case is USA v. Biomet Inc, U.S. District Court, District of
Columbia, No. 12-cr-80.
(Reporting By Brendan Pierson in New York; Editing by David
Gregorio)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|